SI-BONE, Inc. (SIBN) financial statements (2021 and earlier)

Company profile

Business Address 471 EL CAMINO REAL, SUITE 101
SANTA CLARA, CA 95050
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1969325
Cash and cash equivalents541025
Short-term investments14381 
Other undisclosed cash, cash equivalents, and short-term investments(0)1 
Receivables14128
Inventory, net of allowances, customer advances and progress billings653
Inventory653
Deferred costs 0 
Other undisclosed current assets3199
Total current assets:218111136
Noncurrent Assets
Property, plant and equipment542
Long-term investments and receivables 1 
Long-term investments 1 
Other noncurrent assets000
Total noncurrent assets:562
TOTAL ASSETS:223117139
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13149
Accounts payable332
Accrued liabilities10127
Debt 4 
Total current liabilities:13199
Noncurrent Liabilities
Long-term debt and lease obligation393539
Long-term debt, excluding current maturities393539
Liabilities, other than long-term debt100
Other liabilities100
Total noncurrent liabilities:403539
Total liabilities:545448
Stockholders' equity
Stockholders' equity attributable to parent1696390
Common stock000
Additional paid in capital408258247
Accumulated other comprehensive income100
Accumulated deficit(239)(196)(157)
Total stockholders' equity:1696390
TOTAL LIABILITIES AND EQUITY:223117139

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Revenues736755
Cost of revenue
(Cost of Goods and Services Sold)
(9)(7)(5)
Gross profit:646151
Operating expenses(103)(97)(63)
Operating loss:(39)(36)(12)
Nonoperating income (expense)13(0)
Investment income, nonoperating131
Other nonoperating expense(0)(0)(1)
Interest and debt expense(8)(5)(5)
Other undisclosed income from continuing operations before equity method investments, income taxes2  
Loss from continuing operations before income taxes:(44)(38)(17)
Income tax expense(13)(10)(5)
Net loss:(57)(48)(22)
Other undisclosed net income attributable to parent13105
Net loss available to common stockholders, diluted:(44)(38)(17)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(57)(48)(22)
Comprehensive loss:(57)(48)(22)
Other undisclosed comprehensive income, net of tax, attributable to parent13105
Comprehensive loss, net of tax, attributable to parent:(44)(38)(17)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: